SlideShare a Scribd company logo
1 of 21
Download to read offline
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Prepared for: Ethical Standards in Health & Life Sciences Group
By: Jane Fligelstone – The Consortium and Nicky Taylor – Taylor McKenzie
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Objectives of the Survey
• To assess reactions of Individuals, Commercial and Healthcare Organisations
towards the scheme outlined in the Register of Payments Consultation
document

• And in particular, issues of:
• Transparency and public declaration of payments, in a publicly searchable database
• Who should host the scheme and what role HCPs should play
• Whether payments from all types of Life Science companies should be included

• To understand the potential impact that public disclosure of payments could
have on Individuals’ collaboration with Commercial Organisations
NB: This consultation has been funded by the ABPI.
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Methodology
Quantitative
Online Survey

Timings

1055 responses

Survey live

Including 2 not completed online –
BMA and RCGP

28th January – July 5th 2013
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Overall Sample
Total Response

1056

Individuals (40+ mentions)

981

•

Secondary Care Doctor Excluding Psychiatrists

500

•

Psychiatrists

185

•

GPs

75

•

Pharmaceutical Company Employees

63

•

Doctors in Commercial Organisation

47

•

Other Individuals

Commercial Companies

111
64

Healthcare Organisations (large)

8*

Healthcare Organisations (small)

3

* Includes two
questionnaires not done
online, not included in
quantitative analysis
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Sample of Healthcare Organisations
Healthcare Organisations (large)
•

Royal Society of General Practitioners *

•

Royal College of Physicians

•

British Pharmacological Society

•

Guild of Healthcare Pharmacists

•

* Includes two
questionnaires not done
online, not included in
quantitative analysis

British Medical Association *

•

6

College of Optometrists

Private Healthcare Organisations (large)
•

BUPA Health and Wellbeing

•

AXA PPP Healthcare

2
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Sample of Healthcare Organisations
Healthcare Organisations (small)
•

Bedfordshire Clinical Commissioning Group

•

2

Heathway Medical Centre

Private Healthcare Organisations (small)
•

HSC Innovations

1
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Other Individuals in Sample
Individuals - not already shown:
•

Allied Health Professional

7

•

Nurse

3

•

Pharmacist

2

•

Medical Devices / Diagnostics Company Employee

•

Healthcare Manager

11
2

‘Other’ Individuals (not coded):
•

Academic / Research in Medicine

•

Retired

•

Consultant in Pharmaceutical Sector

86
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Sectors of Commercial Organisations
Commercial Organisations
14%
8%

47%

31%

Devices

Pharmaceutical

What sector does your organisation/company belong to? N=64

Bio-Pharma

Other
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Sectors of Healthcare Organisations
Large Healthcare
Organisation - 6
Small Healthcare
Organisation - 2

Large Private Healthcare
Organisation – 2
Small Private Healthcare
Organisation - 1
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Membership of Individuals in Sample
Individual membership (top 6 organisations)
BMA

59%

Royal College of Physicians

56%

Royal College of Psychiatrists

20%

The Royal Society of Medicine

16%

Faculty of Pharmaceutical Medicine

12%

RCGP

9%
0%

Base: 955 Individuals

20%

40%

60%
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Statistical Analysis
• Statistical analysis has been conducted across each respondent type:
•
•
•
•
•

Individuals, Commercial Companies and Healthcare Organisations
Positions of Individuals (HCP, Company employee etc.)
Whether HCPs work in NHS or private practice
Membership of different organisations
Sector of company

• Comments have been added to slides where statistically significant
differences were evident at a 95% level of confidence
Results
REGISTER OF PAYMENTS – CONSULTATION SURVEY
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Scope of Consultation

Issue of
Single,
Transparency
CHALLENGES
Searchable
and Public
Database
FACING PSME
Declaration

Host for
System

HCP
Involvement

Whether
applicable to
all Life
Science
Companies

Effect on
Collaboration
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Transparency of Payments
Almost universal agreement that payments should be transparent
Agree/strongly

Should payments from
commercial organisations to
individually named health care
professionals be transparent?

Total

Neutral/Don’t know

89%

Disagree/strongly

3%

7%

No difference in views of different respondent type

BMA and RCGP agree

Q1: Do you agree or disagree with the principle that payments from commercial organisations to individually named health care professionals should be transparent?
Base: Total sample – 1054
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Public Declaration
Widespread agreement that payments should be publicly declared
Agree/strongly

Should payments from
commercial organisations to
individually named health care
professionals be publicly
declared?

Total

Neutral/Don’t know

77%

Disagree/strongly

9%

15%

No difference in views of different respondent type

BMA and RCGP agree

Q2: Do you agree or disagree with the principle that payments from commercial organisations to individually named health care professionals should be publicly declared ?
Base: Total sample – 1054
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Single, Public Database
Widespread agreement that disclosure should involve central, public database
Agree/strongly

Should system of disclosure take
form of single, publicly
searchable, central database?

Total

Neutral/Don’t know

Disagree/strongly

79%

17%

4%

No difference in views of different respondent type
Those in the Faculty of Pharmaceutical Medicine statistically less likely to
agree (71%) vs. those in BMA (81%)

BMA and RCGP agree
Q3: Do you agree or disagree that a system of disclosure of payments should take the form of a single, publicly searchable, central database?
Base: Those who strongly/agree or neither agree nor disagree that payments should be publicly declared (Q3) – 888
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Host for System of Disclosure
Mixed views on best way of hosting the system
Commercial Companies

Individuals

39%
36%

Regulator
Who should host any system for
declaring payments?

35%

Professional Body
NHS

16%
16%

Government

40%

15%
16%

Trade Body•
Don't know

6%

40%
9%

0%

10%

12%

20%

GMC recommended as
30%
40%
50%
regulator by RCGP

Q4: Who do you think should host any system for declaring payments?
Base: Those who strongly/agree that there should be a single, publicly searchable database (Q4) - Individuals – 651; Commercial Companies - 45
REGISTER OF PAYMENTS – CONSULTATION SURVEY

HCP involvement
Members of most HCP organisations are in favour; the Academy of MRC are less
positive
Neutral/Don’t know
Disagree/strongly
Agree/strongly
Total
Should HCPs play a role in
disclosure of payments?

77%

RCGP

82%

BMA

11% 8%

78%

RCP

76%

RCPE
Academy MRC
BMA and RCGP agree

13% 10%

14%

48%

15%
27%

(N=87)

9%

(N=561)

11%

14%

66%

(N=1054)

(N=538)

20%
24%

(N=61)

(N=29)

Those in the Academy and RCPE statistically less likely to agree vs. those in BMA, RCP and RCGP

Q5: Do you agree or disagree that individual health care professionals should play a role in the disclosure of payments received from commercial organisations (e.g. submitting
information or validating the information submitted by others), alongside the submission of the same information by industry? Base: Total - 1054
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Disclosure for all Life Sciences?
Universal agreement that all types of company should be involved
Agree/strongly

Should disclosure apply to all
types of commercial life sciences
organisations?

Total

Neutral/Don’t know

90%

Disagree/strongly

4%

5%

No difference in views of different respondent type or those in different sectors

RCGP believes there should be a
definitive list of types of companies to
which disclosure applies
Q6: Do you agree or disagree that disclosure of payments to health care professionals should apply to all types of commercial life sciences organisations (e.g. devices,
diagnostics and bio-pharmaceutical industry) and not only the pharmaceutical industry? Base: Total - 1054
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Impact of Public Disclosure on Future Collaboration
with Commercial Organisations
Majority consider that there would be little detrimental effect
Effect of public disclosure of payments on relationship with commercial organisations
Would be more likely to collaborate
Would have no effect on my
collaboration

8% 8%
14%

Would be less likely to collaborate
Don't know •

Little difference according to respondent
type or level of current collaboration;
Psychiatrists tend to consider they would
be ‘more likely’ to collaborate (given
public disclosure of payments) than
Secondary Care doctors (12% vs. 6%)

70%

Q8: What impact would the public disclosure of payments have on your relationship with commercial organisations? Base: All individuals - 964
REGISTER OF PAYMENTS – CONSULTATION SURVEY

Public Disclosure of Payments could reduce collaboration for 1 in 6 who currently

take part in paid activities

Effect of public disclosure on relationship with commercial
organisations – willingness to collaborate in paid activities:

More likely
Currently
participate

Current participation in paid
activities with commercial
organisations

Have
participated in
the past
Have never
participated

4%

7%

14%

Will have no effect

72%

16%

73%

61%

Don’t know

Less likely

8%

16%

9%

15%

Q7: How would you describe your current level of collaboration with commercial organisations?; Q8: What impact would the public disclosure of payments have on your
relationship with commercial organisations? Base: All individuals - 964

5%

(N=264)

(N=465)

(N=236)

More Related Content

What's hot

The FDA and industry: A recipe for collaborating in the New Health Economy
The FDA and industry:  A recipe for collaborating in the New Health EconomyThe FDA and industry:  A recipe for collaborating in the New Health Economy
The FDA and industry: A recipe for collaborating in the New Health EconomyPwC
 
Health Services Tax Conference Day One
Health Services Tax Conference Day OneHealth Services Tax Conference Day One
Health Services Tax Conference Day OnePwC
 
Compliance Today Article November 2015 Schultz
Compliance Today Article November 2015 SchultzCompliance Today Article November 2015 Schultz
Compliance Today Article November 2015 SchultzJanemarie Schultz, MBA
 
How a Real-Time Automated Decision-Support Tool Can Cure the Prior Authorizat...
How a Real-Time Automated Decision-Support Tool Can Cure the Prior Authorizat...How a Real-Time Automated Decision-Support Tool Can Cure the Prior Authorizat...
How a Real-Time Automated Decision-Support Tool Can Cure the Prior Authorizat...Cognizant
 
Healthcare’s Alternative Payment Landscape
Healthcare’s Alternative Payment LandscapeHealthcare’s Alternative Payment Landscape
Healthcare’s Alternative Payment LandscapePwC
 
CRI White Paper 2014
CRI White Paper 2014CRI White Paper 2014
CRI White Paper 2014Caryn Enderle
 
Practice Perspectives 2016
Practice Perspectives 2016Practice Perspectives 2016
Practice Perspectives 2016Kareo
 
Industry Insights Healthcare Information Technology - October 2016
Industry Insights Healthcare Information Technology - October 2016Industry Insights Healthcare Information Technology - October 2016
Industry Insights Healthcare Information Technology - October 2016Duff & Phelps
 
Automated Prior Authorization: A High-Value Opportunity
Automated Prior Authorization: A High-Value OpportunityAutomated Prior Authorization: A High-Value Opportunity
Automated Prior Authorization: A High-Value OpportunityCognizant
 
How Providers Can Reshape their Operations to Master Value-Based Reimbursements
How Providers Can Reshape their Operations to Master Value-Based ReimbursementsHow Providers Can Reshape their Operations to Master Value-Based Reimbursements
How Providers Can Reshape their Operations to Master Value-Based ReimbursementsCognizant
 
Lab42 - A Closer Look at Healthcare Q1 2014
Lab42 - A Closer Look at Healthcare Q1 2014Lab42 - A Closer Look at Healthcare Q1 2014
Lab42 - A Closer Look at Healthcare Q1 2014Robert Maihofer
 
Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...
Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...
Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...Justin Campbell
 
Best Practices for Physician Call Coverage Compensation
Best Practices for Physician Call Coverage CompensationBest Practices for Physician Call Coverage Compensation
Best Practices for Physician Call Coverage CompensationMD Ranger, Inc.
 
Pres hsr mar5_lukanen
Pres hsr mar5_lukanenPres hsr mar5_lukanen
Pres hsr mar5_lukanensoder145
 
TITAN Frequently Asked Questions
TITAN Frequently Asked QuestionsTITAN Frequently Asked Questions
TITAN Frequently Asked QuestionsTheTitanGroupLLC
 
Creating the digital patient home
Creating the digital patient homeCreating the digital patient home
Creating the digital patient homeGeorge Van Antwerp
 
How to Engage Physicians in Best Practices to Respond to Healthcare Transform...
How to Engage Physicians in Best Practices to Respond to Healthcare Transform...How to Engage Physicians in Best Practices to Respond to Healthcare Transform...
How to Engage Physicians in Best Practices to Respond to Healthcare Transform...PYA, P.C.
 

What's hot (20)

The FDA and industry: A recipe for collaborating in the New Health Economy
The FDA and industry:  A recipe for collaborating in the New Health EconomyThe FDA and industry:  A recipe for collaborating in the New Health Economy
The FDA and industry: A recipe for collaborating in the New Health Economy
 
Health Services Tax Conference Day One
Health Services Tax Conference Day OneHealth Services Tax Conference Day One
Health Services Tax Conference Day One
 
Compliance Today Article November 2015 Schultz
Compliance Today Article November 2015 SchultzCompliance Today Article November 2015 Schultz
Compliance Today Article November 2015 Schultz
 
Cats Corporate Presentation
Cats Corporate PresentationCats Corporate Presentation
Cats Corporate Presentation
 
How a Real-Time Automated Decision-Support Tool Can Cure the Prior Authorizat...
How a Real-Time Automated Decision-Support Tool Can Cure the Prior Authorizat...How a Real-Time Automated Decision-Support Tool Can Cure the Prior Authorizat...
How a Real-Time Automated Decision-Support Tool Can Cure the Prior Authorizat...
 
Healthcare’s Alternative Payment Landscape
Healthcare’s Alternative Payment LandscapeHealthcare’s Alternative Payment Landscape
Healthcare’s Alternative Payment Landscape
 
CRI White Paper 2014
CRI White Paper 2014CRI White Paper 2014
CRI White Paper 2014
 
Practice Perspectives 2016
Practice Perspectives 2016Practice Perspectives 2016
Practice Perspectives 2016
 
Industry Insights Healthcare Information Technology - October 2016
Industry Insights Healthcare Information Technology - October 2016Industry Insights Healthcare Information Technology - October 2016
Industry Insights Healthcare Information Technology - October 2016
 
Automated Prior Authorization: A High-Value Opportunity
Automated Prior Authorization: A High-Value OpportunityAutomated Prior Authorization: A High-Value Opportunity
Automated Prior Authorization: A High-Value Opportunity
 
How Providers Can Reshape their Operations to Master Value-Based Reimbursements
How Providers Can Reshape their Operations to Master Value-Based ReimbursementsHow Providers Can Reshape their Operations to Master Value-Based Reimbursements
How Providers Can Reshape their Operations to Master Value-Based Reimbursements
 
Macra 2017
Macra 2017Macra 2017
Macra 2017
 
Lab42 - A Closer Look at Healthcare Q1 2014
Lab42 - A Closer Look at Healthcare Q1 2014Lab42 - A Closer Look at Healthcare Q1 2014
Lab42 - A Closer Look at Healthcare Q1 2014
 
Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...
Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...
Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...
 
HM311 Ab103417 ch10
HM311 Ab103417 ch10HM311 Ab103417 ch10
HM311 Ab103417 ch10
 
Best Practices for Physician Call Coverage Compensation
Best Practices for Physician Call Coverage CompensationBest Practices for Physician Call Coverage Compensation
Best Practices for Physician Call Coverage Compensation
 
Pres hsr mar5_lukanen
Pres hsr mar5_lukanenPres hsr mar5_lukanen
Pres hsr mar5_lukanen
 
TITAN Frequently Asked Questions
TITAN Frequently Asked QuestionsTITAN Frequently Asked Questions
TITAN Frequently Asked Questions
 
Creating the digital patient home
Creating the digital patient homeCreating the digital patient home
Creating the digital patient home
 
How to Engage Physicians in Best Practices to Respond to Healthcare Transform...
How to Engage Physicians in Best Practices to Respond to Healthcare Transform...How to Engage Physicians in Best Practices to Respond to Healthcare Transform...
How to Engage Physicians in Best Practices to Respond to Healthcare Transform...
 

Viewers also liked

Global Transparency Reporting Congress
Global Transparency Reporting CongressGlobal Transparency Reporting Congress
Global Transparency Reporting CongressMarket iT
 
Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...
Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...
Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...Market iT
 
Pharma compliance EU 2015
Pharma compliance EU 2015Pharma compliance EU 2015
Pharma compliance EU 2015Market iT
 
Strategie e sante-2020
Strategie e sante-2020Strategie e sante-2020
Strategie e sante-2020Market iT
 
Public Notification of Emerging Postmarket Medical Device Signals
Public Notification of Emerging  Postmarket Medical Device SignalsPublic Notification of Emerging  Postmarket Medical Device Signals
Public Notification of Emerging Postmarket Medical Device SignalsMarket iT
 
Global MedTech Compliance Conference 2015
Global MedTech Compliance Conference 2015Global MedTech Compliance Conference 2015
Global MedTech Compliance Conference 2015Market iT
 
Jeudi 17 mars 2016 | Marchés publics, pratiques abusives et discriminantes :...
Jeudi 17 mars 2016  | Marchés publics, pratiques abusives et discriminantes :...Jeudi 17 mars 2016  | Marchés publics, pratiques abusives et discriminantes :...
Jeudi 17 mars 2016 | Marchés publics, pratiques abusives et discriminantes :...Market iT
 
Sia partners baromètrepratiquesdigitales2016_cp_info
Sia partners baromètrepratiquesdigitales2016_cp_infoSia partners baromètrepratiquesdigitales2016_cp_info
Sia partners baromètrepratiquesdigitales2016_cp_infoMarket iT
 
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...Market iT
 
11.04.2016 rapport conseil_strategique_des_industries_de_sante
11.04.2016 rapport conseil_strategique_des_industries_de_sante11.04.2016 rapport conseil_strategique_des_industries_de_sante
11.04.2016 rapport conseil_strategique_des_industries_de_santeMarket iT
 
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...Market iT
 
2nd European Conference on Clinical Research
2nd European Conference on Clinical Research2nd European Conference on Clinical Research
2nd European Conference on Clinical ResearchMarket iT
 
Jeudi 10 mars 2016 | Audit DMOS & Transparence
Jeudi 10 mars 2016 | Audit DMOS & TransparenceJeudi 10 mars 2016 | Audit DMOS & Transparence
Jeudi 10 mars 2016 | Audit DMOS & TransparenceMarket iT
 
Iffres 31 03-2016 présentation matinale santé Market iT
Iffres 31 03-2016  présentation matinale santé Market iTIffres 31 03-2016  présentation matinale santé Market iT
Iffres 31 03-2016 présentation matinale santé Market iTMarket iT
 
Sfee press release_disclosure_code_20141009_2
Sfee press release_disclosure_code_20141009_2Sfee press release_disclosure_code_20141009_2
Sfee press release_disclosure_code_20141009_2Market iT
 
Open payments user guide [august-2014]
Open payments user guide [august-2014]Open payments user guide [august-2014]
Open payments user guide [august-2014]Market iT
 
The Medicines Australia Code of Conduct : Summary of the changes included in ...
The Medicines Australia Code of Conduct : Summary of the changes included in ...The Medicines Australia Code of Conduct : Summary of the changes included in ...
The Medicines Australia Code of Conduct : Summary of the changes included in ...Market iT
 
Projet de Loi de modernisation de notre système de santé 2015
Projet de Loi de modernisation de notre système de santé 2015Projet de Loi de modernisation de notre système de santé 2015
Projet de Loi de modernisation de notre système de santé 2015Market iT
 
The Medicines Australia Code of Conduct
The Medicines Australia Code of ConductThe Medicines Australia Code of Conduct
The Medicines Australia Code of ConductMarket iT
 
3rd corporate compliance & transparency in pharma
3rd corporate compliance & transparency in pharma3rd corporate compliance & transparency in pharma
3rd corporate compliance & transparency in pharmaMarket iT
 

Viewers also liked (20)

Global Transparency Reporting Congress
Global Transparency Reporting CongressGlobal Transparency Reporting Congress
Global Transparency Reporting Congress
 
Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...
Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...
Nouvelles recommandations de la FDA sur la sécurité informatique des fabrican...
 
Pharma compliance EU 2015
Pharma compliance EU 2015Pharma compliance EU 2015
Pharma compliance EU 2015
 
Strategie e sante-2020
Strategie e sante-2020Strategie e sante-2020
Strategie e sante-2020
 
Public Notification of Emerging Postmarket Medical Device Signals
Public Notification of Emerging  Postmarket Medical Device SignalsPublic Notification of Emerging  Postmarket Medical Device Signals
Public Notification of Emerging Postmarket Medical Device Signals
 
Global MedTech Compliance Conference 2015
Global MedTech Compliance Conference 2015Global MedTech Compliance Conference 2015
Global MedTech Compliance Conference 2015
 
Jeudi 17 mars 2016 | Marchés publics, pratiques abusives et discriminantes :...
Jeudi 17 mars 2016  | Marchés publics, pratiques abusives et discriminantes :...Jeudi 17 mars 2016  | Marchés publics, pratiques abusives et discriminantes :...
Jeudi 17 mars 2016 | Marchés publics, pratiques abusives et discriminantes :...
 
Sia partners baromètrepratiquesdigitales2016_cp_info
Sia partners baromètrepratiquesdigitales2016_cp_infoSia partners baromètrepratiquesdigitales2016_cp_info
Sia partners baromètrepratiquesdigitales2016_cp_info
 
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
Mercredi 30 et jeudi 31 mars 2016 | Gérer un recours produit : conditions de ...
 
11.04.2016 rapport conseil_strategique_des_industries_de_sante
11.04.2016 rapport conseil_strategique_des_industries_de_sante11.04.2016 rapport conseil_strategique_des_industries_de_sante
11.04.2016 rapport conseil_strategique_des_industries_de_sante
 
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...
Financial Disclosures in Academic Publications and the Sunshine Act: A Concor...
 
2nd European Conference on Clinical Research
2nd European Conference on Clinical Research2nd European Conference on Clinical Research
2nd European Conference on Clinical Research
 
Jeudi 10 mars 2016 | Audit DMOS & Transparence
Jeudi 10 mars 2016 | Audit DMOS & TransparenceJeudi 10 mars 2016 | Audit DMOS & Transparence
Jeudi 10 mars 2016 | Audit DMOS & Transparence
 
Iffres 31 03-2016 présentation matinale santé Market iT
Iffres 31 03-2016  présentation matinale santé Market iTIffres 31 03-2016  présentation matinale santé Market iT
Iffres 31 03-2016 présentation matinale santé Market iT
 
Sfee press release_disclosure_code_20141009_2
Sfee press release_disclosure_code_20141009_2Sfee press release_disclosure_code_20141009_2
Sfee press release_disclosure_code_20141009_2
 
Open payments user guide [august-2014]
Open payments user guide [august-2014]Open payments user guide [august-2014]
Open payments user guide [august-2014]
 
The Medicines Australia Code of Conduct : Summary of the changes included in ...
The Medicines Australia Code of Conduct : Summary of the changes included in ...The Medicines Australia Code of Conduct : Summary of the changes included in ...
The Medicines Australia Code of Conduct : Summary of the changes included in ...
 
Projet de Loi de modernisation de notre système de santé 2015
Projet de Loi de modernisation de notre système de santé 2015Projet de Loi de modernisation de notre système de santé 2015
Projet de Loi de modernisation de notre système de santé 2015
 
The Medicines Australia Code of Conduct
The Medicines Australia Code of ConductThe Medicines Australia Code of Conduct
The Medicines Australia Code of Conduct
 
3rd corporate compliance & transparency in pharma
3rd corporate compliance & transparency in pharma3rd corporate compliance & transparency in pharma
3rd corporate compliance & transparency in pharma
 

Similar to Eshlsg consultation-results-october2013

Presentation for spbt 2013 meeting background and research
Presentation for spbt 2013 meeting background and researchPresentation for spbt 2013 meeting background and research
Presentation for spbt 2013 meeting background and researchklaffy
 
The Future of Transparency: Five Pillars for Global Success
The Future of Transparency: Five Pillars for Global SuccessThe Future of Transparency: Five Pillars for Global Success
The Future of Transparency: Five Pillars for Global Successpharmacertify
 
AMA Digital Health Study
AMA Digital Health Study AMA Digital Health Study
AMA Digital Health Study Brian Ahier
 
Uncover Emerging Strategies for Managing Patient Data
Uncover Emerging Strategies for Managing Patient DataUncover Emerging Strategies for Managing Patient Data
Uncover Emerging Strategies for Managing Patient DataHelio Health Group
 
Marketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric HealthcareMarketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric HealthcareOgilvy Consulting
 
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...Levi Shapiro
 
Disruptive trends impacting the healthcare industry...
Disruptive trends impacting the healthcare industry...Disruptive trends impacting the healthcare industry...
Disruptive trends impacting the healthcare industry...Tim Ziakas
 
How Health Plans Can Thrive in Today's Post-Reform Consumer Marketplace [Prev...
How Health Plans Can Thrive in Today's Post-Reform Consumer Marketplace [Prev...How Health Plans Can Thrive in Today's Post-Reform Consumer Marketplace [Prev...
How Health Plans Can Thrive in Today's Post-Reform Consumer Marketplace [Prev...WEX Health Trends and Insights
 
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Best Practices
 
Will raising taxes resolve the NHS finances
Will raising taxes resolve the NHS financesWill raising taxes resolve the NHS finances
Will raising taxes resolve the NHS financesMatthew Allen
 
HealthXL Digital Health Success Stories Report Part One
HealthXL Digital Health Success Stories Report Part OneHealthXL Digital Health Success Stories Report Part One
HealthXL Digital Health Success Stories Report Part OneMaeve Lyons
 
Todd Berner: Assessment of Payer ACOs: Industry's Role
Todd Berner: Assessment of Payer ACOs: Industry's RoleTodd Berner: Assessment of Payer ACOs: Industry's Role
Todd Berner: Assessment of Payer ACOs: Industry's RoleTodd Berner MD
 
Oldham Health Commission
Oldham Health CommissionOldham Health Commission
Oldham Health CommissionNHSOldham
 
By the Numbers: The Importance of Healthcare Consumer Experience
By the Numbers: The Importance of Healthcare Consumer ExperienceBy the Numbers: The Importance of Healthcare Consumer Experience
By the Numbers: The Importance of Healthcare Consumer ExperienceInfluence Health
 
Resource Allocation and Purchasing: What do we need to know and why?
Resource Allocation and Purchasing: What do we need to know and why?Resource Allocation and Purchasing: What do we need to know and why?
Resource Allocation and Purchasing: What do we need to know and why?HFG Project
 
Joint Working workshop
Joint Working workshopJoint Working workshop
Joint Working workshopPM Society
 
People, health professionals and health information Working together in 2014
People, health professionals and health information Working together in 2014People, health professionals and health information Working together in 2014
People, health professionals and health information Working together in 2014Health Informatics New Zealand
 
mHealth India- bringing telcos and providers together
mHealth India- bringing telcos and providers togethermHealth India- bringing telcos and providers together
mHealth India- bringing telcos and providers togetherHELATHCURSOR CONSULTING GROUP
 

Similar to Eshlsg consultation-results-october2013 (20)

Presentation for spbt 2013 meeting background and research
Presentation for spbt 2013 meeting background and researchPresentation for spbt 2013 meeting background and research
Presentation for spbt 2013 meeting background and research
 
The Future of Transparency: Five Pillars for Global Success
The Future of Transparency: Five Pillars for Global SuccessThe Future of Transparency: Five Pillars for Global Success
The Future of Transparency: Five Pillars for Global Success
 
AMA Digital Health Study
AMA Digital Health Study AMA Digital Health Study
AMA Digital Health Study
 
Uncover Emerging Strategies for Managing Patient Data
Uncover Emerging Strategies for Managing Patient DataUncover Emerging Strategies for Managing Patient Data
Uncover Emerging Strategies for Managing Patient Data
 
Marketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric HealthcareMarketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric Healthcare
 
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...
mHealth Israel_GEARING COMMUNICATIONS TO RAISE CAPITAL AND ATTRACT CUSTOMERS_...
 
Disruptive trends impacting the healthcare industry...
Disruptive trends impacting the healthcare industry...Disruptive trends impacting the healthcare industry...
Disruptive trends impacting the healthcare industry...
 
Community Pharmacy Owners and the NZHIT Plan
Community Pharmacy Owners and the NZHIT PlanCommunity Pharmacy Owners and the NZHIT Plan
Community Pharmacy Owners and the NZHIT Plan
 
How Health Plans Can Thrive in Today's Post-Reform Consumer Marketplace [Prev...
How Health Plans Can Thrive in Today's Post-Reform Consumer Marketplace [Prev...How Health Plans Can Thrive in Today's Post-Reform Consumer Marketplace [Prev...
How Health Plans Can Thrive in Today's Post-Reform Consumer Marketplace [Prev...
 
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
 
Will raising taxes resolve the NHS finances
Will raising taxes resolve the NHS financesWill raising taxes resolve the NHS finances
Will raising taxes resolve the NHS finances
 
Dr Rachel David
Dr Rachel DavidDr Rachel David
Dr Rachel David
 
HealthXL Digital Health Success Stories Report Part One
HealthXL Digital Health Success Stories Report Part OneHealthXL Digital Health Success Stories Report Part One
HealthXL Digital Health Success Stories Report Part One
 
Todd Berner: Assessment of Payer ACOs: Industry's Role
Todd Berner: Assessment of Payer ACOs: Industry's RoleTodd Berner: Assessment of Payer ACOs: Industry's Role
Todd Berner: Assessment of Payer ACOs: Industry's Role
 
Oldham Health Commission
Oldham Health CommissionOldham Health Commission
Oldham Health Commission
 
By the Numbers: The Importance of Healthcare Consumer Experience
By the Numbers: The Importance of Healthcare Consumer ExperienceBy the Numbers: The Importance of Healthcare Consumer Experience
By the Numbers: The Importance of Healthcare Consumer Experience
 
Resource Allocation and Purchasing: What do we need to know and why?
Resource Allocation and Purchasing: What do we need to know and why?Resource Allocation and Purchasing: What do we need to know and why?
Resource Allocation and Purchasing: What do we need to know and why?
 
Joint Working workshop
Joint Working workshopJoint Working workshop
Joint Working workshop
 
People, health professionals and health information Working together in 2014
People, health professionals and health information Working together in 2014People, health professionals and health information Working together in 2014
People, health professionals and health information Working together in 2014
 
mHealth India- bringing telcos and providers together
mHealth India- bringing telcos and providers togethermHealth India- bringing telcos and providers together
mHealth India- bringing telcos and providers together
 

More from Market iT

LOI n o 2018-493 du 20 juin 2018 relative à la protection des données ...
LOI n o  2018-493  du 20 juin 2018   relative  à la protection  des données  ...LOI n o  2018-493  du 20 juin 2018   relative  à la protection  des données  ...
LOI n o 2018-493 du 20 juin 2018 relative à la protection des données ...Market iT
 
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...Market iT
 
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...Market iT
 
Loi sapin II
Loi sapin IILoi sapin II
Loi sapin IIMarket iT
 
Guide lanceur d'alerte
Guide lanceur d'alerteGuide lanceur d'alerte
Guide lanceur d'alerteMarket iT
 
TRansparency International : 2018 guide for whistleblowing legislation
TRansparency International : 2018 guide for whistleblowing legislationTRansparency International : 2018 guide for whistleblowing legislation
TRansparency International : 2018 guide for whistleblowing legislationMarket iT
 
SAPIN 2 : Decret lanceur d'alerte 19-04-2017
SAPIN 2 : Decret lanceur d'alerte 19-04-2017SAPIN 2 : Decret lanceur d'alerte 19-04-2017
SAPIN 2 : Decret lanceur d'alerte 19-04-2017Market iT
 
Transparency International : Guide lanceur d'alerte
Transparency International : Guide lanceur d'alerteTransparency International : Guide lanceur d'alerte
Transparency International : Guide lanceur d'alerteMarket iT
 
Espace annonceurs PharmaCompliance.info tarifs_on_line
Espace annonceurs PharmaCompliance.info tarifs_on_lineEspace annonceurs PharmaCompliance.info tarifs_on_line
Espace annonceurs PharmaCompliance.info tarifs_on_lineMarket iT
 
Guidelines on consent under GDPR
Guidelines on consent under GDPRGuidelines on consent under GDPR
Guidelines on consent under GDPRMarket iT
 
MedTech europe code of ethical business practice
MedTech europe code of ethical business practiceMedTech europe code of ethical business practice
MedTech europe code of ethical business practiceMarket iT
 
Un logiciel peut il constituer un dispositif médical
Un logiciel peut il constituer un dispositif médicalUn logiciel peut il constituer un dispositif médical
Un logiciel peut il constituer un dispositif médicalMarket iT
 
Le canard enchainé 2017.11.08 - des labos soignant l'éthique
Le canard enchainé   2017.11.08 - des labos soignant l'éthiqueLe canard enchainé   2017.11.08 - des labos soignant l'éthique
Le canard enchainé 2017.11.08 - des labos soignant l'éthiqueMarket iT
 
analyse d’impact relative à la protection des données (DPIA)
analyse d’impact relative à la protection des données (DPIA)analyse d’impact relative à la protection des données (DPIA)
analyse d’impact relative à la protection des données (DPIA)Market iT
 
Mission « flash » sur le Levothyrox
Mission « flash » sur le Levothyrox Mission « flash » sur le Levothyrox
Mission « flash » sur le Levothyrox Market iT
 
Programme universite des DPO - AFCDP 24 janvier 2018
Programme universite des DPO - AFCDP 24 janvier 2018Programme universite des DPO - AFCDP 24 janvier 2018
Programme universite des DPO - AFCDP 24 janvier 2018Market iT
 
Cybersécurité des dispositifs médicaux
Cybersécurité des dispositifs médicauxCybersécurité des dispositifs médicaux
Cybersécurité des dispositifs médicauxMarket iT
 
HAS Rapport annuel deontologue_2016
HAS Rapport annuel deontologue_2016HAS Rapport annuel deontologue_2016
HAS Rapport annuel deontologue_2016Market iT
 
Corporate reputation of pharma in 2016
Corporate reputation of pharma in 2016Corporate reputation of pharma in 2016
Corporate reputation of pharma in 2016Market iT
 
Codeem rapport d'activité 2016
Codeem rapport d'activité 2016Codeem rapport d'activité 2016
Codeem rapport d'activité 2016Market iT
 

More from Market iT (20)

LOI n o 2018-493 du 20 juin 2018 relative à la protection des données ...
LOI n o  2018-493  du 20 juin 2018   relative  à la protection  des données  ...LOI n o  2018-493  du 20 juin 2018   relative  à la protection  des données  ...
LOI n o 2018-493 du 20 juin 2018 relative à la protection des données ...
 
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
Guide cnom-cnil : RGPD : le Conseil National de l’Ordre des Médecins et la CN...
 
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
Rapport du Sénat sur les MÉDICAMENTS INNOVANTS : CONSOLIDER LE MODÈLE FRANÇAI...
 
Loi sapin II
Loi sapin IILoi sapin II
Loi sapin II
 
Guide lanceur d'alerte
Guide lanceur d'alerteGuide lanceur d'alerte
Guide lanceur d'alerte
 
TRansparency International : 2018 guide for whistleblowing legislation
TRansparency International : 2018 guide for whistleblowing legislationTRansparency International : 2018 guide for whistleblowing legislation
TRansparency International : 2018 guide for whistleblowing legislation
 
SAPIN 2 : Decret lanceur d'alerte 19-04-2017
SAPIN 2 : Decret lanceur d'alerte 19-04-2017SAPIN 2 : Decret lanceur d'alerte 19-04-2017
SAPIN 2 : Decret lanceur d'alerte 19-04-2017
 
Transparency International : Guide lanceur d'alerte
Transparency International : Guide lanceur d'alerteTransparency International : Guide lanceur d'alerte
Transparency International : Guide lanceur d'alerte
 
Espace annonceurs PharmaCompliance.info tarifs_on_line
Espace annonceurs PharmaCompliance.info tarifs_on_lineEspace annonceurs PharmaCompliance.info tarifs_on_line
Espace annonceurs PharmaCompliance.info tarifs_on_line
 
Guidelines on consent under GDPR
Guidelines on consent under GDPRGuidelines on consent under GDPR
Guidelines on consent under GDPR
 
MedTech europe code of ethical business practice
MedTech europe code of ethical business practiceMedTech europe code of ethical business practice
MedTech europe code of ethical business practice
 
Un logiciel peut il constituer un dispositif médical
Un logiciel peut il constituer un dispositif médicalUn logiciel peut il constituer un dispositif médical
Un logiciel peut il constituer un dispositif médical
 
Le canard enchainé 2017.11.08 - des labos soignant l'éthique
Le canard enchainé   2017.11.08 - des labos soignant l'éthiqueLe canard enchainé   2017.11.08 - des labos soignant l'éthique
Le canard enchainé 2017.11.08 - des labos soignant l'éthique
 
analyse d’impact relative à la protection des données (DPIA)
analyse d’impact relative à la protection des données (DPIA)analyse d’impact relative à la protection des données (DPIA)
analyse d’impact relative à la protection des données (DPIA)
 
Mission « flash » sur le Levothyrox
Mission « flash » sur le Levothyrox Mission « flash » sur le Levothyrox
Mission « flash » sur le Levothyrox
 
Programme universite des DPO - AFCDP 24 janvier 2018
Programme universite des DPO - AFCDP 24 janvier 2018Programme universite des DPO - AFCDP 24 janvier 2018
Programme universite des DPO - AFCDP 24 janvier 2018
 
Cybersécurité des dispositifs médicaux
Cybersécurité des dispositifs médicauxCybersécurité des dispositifs médicaux
Cybersécurité des dispositifs médicaux
 
HAS Rapport annuel deontologue_2016
HAS Rapport annuel deontologue_2016HAS Rapport annuel deontologue_2016
HAS Rapport annuel deontologue_2016
 
Corporate reputation of pharma in 2016
Corporate reputation of pharma in 2016Corporate reputation of pharma in 2016
Corporate reputation of pharma in 2016
 
Codeem rapport d'activité 2016
Codeem rapport d'activité 2016Codeem rapport d'activité 2016
Codeem rapport d'activité 2016
 

Recently uploaded

call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 

Recently uploaded (20)

call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 

Eshlsg consultation-results-october2013

  • 1. REGISTER OF PAYMENTS – CONSULTATION SURVEY Prepared for: Ethical Standards in Health & Life Sciences Group By: Jane Fligelstone – The Consortium and Nicky Taylor – Taylor McKenzie
  • 2. REGISTER OF PAYMENTS – CONSULTATION SURVEY Objectives of the Survey • To assess reactions of Individuals, Commercial and Healthcare Organisations towards the scheme outlined in the Register of Payments Consultation document • And in particular, issues of: • Transparency and public declaration of payments, in a publicly searchable database • Who should host the scheme and what role HCPs should play • Whether payments from all types of Life Science companies should be included • To understand the potential impact that public disclosure of payments could have on Individuals’ collaboration with Commercial Organisations NB: This consultation has been funded by the ABPI.
  • 3. REGISTER OF PAYMENTS – CONSULTATION SURVEY Methodology Quantitative Online Survey Timings 1055 responses Survey live Including 2 not completed online – BMA and RCGP 28th January – July 5th 2013
  • 4. REGISTER OF PAYMENTS – CONSULTATION SURVEY Overall Sample Total Response 1056 Individuals (40+ mentions) 981 • Secondary Care Doctor Excluding Psychiatrists 500 • Psychiatrists 185 • GPs 75 • Pharmaceutical Company Employees 63 • Doctors in Commercial Organisation 47 • Other Individuals Commercial Companies 111 64 Healthcare Organisations (large) 8* Healthcare Organisations (small) 3 * Includes two questionnaires not done online, not included in quantitative analysis
  • 5. REGISTER OF PAYMENTS – CONSULTATION SURVEY Sample of Healthcare Organisations Healthcare Organisations (large) • Royal Society of General Practitioners * • Royal College of Physicians • British Pharmacological Society • Guild of Healthcare Pharmacists • * Includes two questionnaires not done online, not included in quantitative analysis British Medical Association * • 6 College of Optometrists Private Healthcare Organisations (large) • BUPA Health and Wellbeing • AXA PPP Healthcare 2
  • 6. REGISTER OF PAYMENTS – CONSULTATION SURVEY Sample of Healthcare Organisations Healthcare Organisations (small) • Bedfordshire Clinical Commissioning Group • 2 Heathway Medical Centre Private Healthcare Organisations (small) • HSC Innovations 1
  • 7. REGISTER OF PAYMENTS – CONSULTATION SURVEY Other Individuals in Sample Individuals - not already shown: • Allied Health Professional 7 • Nurse 3 • Pharmacist 2 • Medical Devices / Diagnostics Company Employee • Healthcare Manager 11 2 ‘Other’ Individuals (not coded): • Academic / Research in Medicine • Retired • Consultant in Pharmaceutical Sector 86
  • 8. REGISTER OF PAYMENTS – CONSULTATION SURVEY Sectors of Commercial Organisations Commercial Organisations 14% 8% 47% 31% Devices Pharmaceutical What sector does your organisation/company belong to? N=64 Bio-Pharma Other
  • 9. REGISTER OF PAYMENTS – CONSULTATION SURVEY Sectors of Healthcare Organisations Large Healthcare Organisation - 6 Small Healthcare Organisation - 2 Large Private Healthcare Organisation – 2 Small Private Healthcare Organisation - 1
  • 10. REGISTER OF PAYMENTS – CONSULTATION SURVEY Membership of Individuals in Sample Individual membership (top 6 organisations) BMA 59% Royal College of Physicians 56% Royal College of Psychiatrists 20% The Royal Society of Medicine 16% Faculty of Pharmaceutical Medicine 12% RCGP 9% 0% Base: 955 Individuals 20% 40% 60%
  • 11. REGISTER OF PAYMENTS – CONSULTATION SURVEY Statistical Analysis • Statistical analysis has been conducted across each respondent type: • • • • • Individuals, Commercial Companies and Healthcare Organisations Positions of Individuals (HCP, Company employee etc.) Whether HCPs work in NHS or private practice Membership of different organisations Sector of company • Comments have been added to slides where statistically significant differences were evident at a 95% level of confidence
  • 12. Results REGISTER OF PAYMENTS – CONSULTATION SURVEY
  • 13. REGISTER OF PAYMENTS – CONSULTATION SURVEY Scope of Consultation Issue of Single, Transparency CHALLENGES Searchable and Public Database FACING PSME Declaration Host for System HCP Involvement Whether applicable to all Life Science Companies Effect on Collaboration
  • 14. REGISTER OF PAYMENTS – CONSULTATION SURVEY Transparency of Payments Almost universal agreement that payments should be transparent Agree/strongly Should payments from commercial organisations to individually named health care professionals be transparent? Total Neutral/Don’t know 89% Disagree/strongly 3% 7% No difference in views of different respondent type BMA and RCGP agree Q1: Do you agree or disagree with the principle that payments from commercial organisations to individually named health care professionals should be transparent? Base: Total sample – 1054
  • 15. REGISTER OF PAYMENTS – CONSULTATION SURVEY Public Declaration Widespread agreement that payments should be publicly declared Agree/strongly Should payments from commercial organisations to individually named health care professionals be publicly declared? Total Neutral/Don’t know 77% Disagree/strongly 9% 15% No difference in views of different respondent type BMA and RCGP agree Q2: Do you agree or disagree with the principle that payments from commercial organisations to individually named health care professionals should be publicly declared ? Base: Total sample – 1054
  • 16. REGISTER OF PAYMENTS – CONSULTATION SURVEY Single, Public Database Widespread agreement that disclosure should involve central, public database Agree/strongly Should system of disclosure take form of single, publicly searchable, central database? Total Neutral/Don’t know Disagree/strongly 79% 17% 4% No difference in views of different respondent type Those in the Faculty of Pharmaceutical Medicine statistically less likely to agree (71%) vs. those in BMA (81%) BMA and RCGP agree Q3: Do you agree or disagree that a system of disclosure of payments should take the form of a single, publicly searchable, central database? Base: Those who strongly/agree or neither agree nor disagree that payments should be publicly declared (Q3) – 888
  • 17. REGISTER OF PAYMENTS – CONSULTATION SURVEY Host for System of Disclosure Mixed views on best way of hosting the system Commercial Companies Individuals 39% 36% Regulator Who should host any system for declaring payments? 35% Professional Body NHS 16% 16% Government 40% 15% 16% Trade Body• Don't know 6% 40% 9% 0% 10% 12% 20% GMC recommended as 30% 40% 50% regulator by RCGP Q4: Who do you think should host any system for declaring payments? Base: Those who strongly/agree that there should be a single, publicly searchable database (Q4) - Individuals – 651; Commercial Companies - 45
  • 18. REGISTER OF PAYMENTS – CONSULTATION SURVEY HCP involvement Members of most HCP organisations are in favour; the Academy of MRC are less positive Neutral/Don’t know Disagree/strongly Agree/strongly Total Should HCPs play a role in disclosure of payments? 77% RCGP 82% BMA 11% 8% 78% RCP 76% RCPE Academy MRC BMA and RCGP agree 13% 10% 14% 48% 15% 27% (N=87) 9% (N=561) 11% 14% 66% (N=1054) (N=538) 20% 24% (N=61) (N=29) Those in the Academy and RCPE statistically less likely to agree vs. those in BMA, RCP and RCGP Q5: Do you agree or disagree that individual health care professionals should play a role in the disclosure of payments received from commercial organisations (e.g. submitting information or validating the information submitted by others), alongside the submission of the same information by industry? Base: Total - 1054
  • 19. REGISTER OF PAYMENTS – CONSULTATION SURVEY Disclosure for all Life Sciences? Universal agreement that all types of company should be involved Agree/strongly Should disclosure apply to all types of commercial life sciences organisations? Total Neutral/Don’t know 90% Disagree/strongly 4% 5% No difference in views of different respondent type or those in different sectors RCGP believes there should be a definitive list of types of companies to which disclosure applies Q6: Do you agree or disagree that disclosure of payments to health care professionals should apply to all types of commercial life sciences organisations (e.g. devices, diagnostics and bio-pharmaceutical industry) and not only the pharmaceutical industry? Base: Total - 1054
  • 20. REGISTER OF PAYMENTS – CONSULTATION SURVEY Impact of Public Disclosure on Future Collaboration with Commercial Organisations Majority consider that there would be little detrimental effect Effect of public disclosure of payments on relationship with commercial organisations Would be more likely to collaborate Would have no effect on my collaboration 8% 8% 14% Would be less likely to collaborate Don't know • Little difference according to respondent type or level of current collaboration; Psychiatrists tend to consider they would be ‘more likely’ to collaborate (given public disclosure of payments) than Secondary Care doctors (12% vs. 6%) 70% Q8: What impact would the public disclosure of payments have on your relationship with commercial organisations? Base: All individuals - 964
  • 21. REGISTER OF PAYMENTS – CONSULTATION SURVEY Public Disclosure of Payments could reduce collaboration for 1 in 6 who currently take part in paid activities Effect of public disclosure on relationship with commercial organisations – willingness to collaborate in paid activities: More likely Currently participate Current participation in paid activities with commercial organisations Have participated in the past Have never participated 4% 7% 14% Will have no effect 72% 16% 73% 61% Don’t know Less likely 8% 16% 9% 15% Q7: How would you describe your current level of collaboration with commercial organisations?; Q8: What impact would the public disclosure of payments have on your relationship with commercial organisations? Base: All individuals - 964 5% (N=264) (N=465) (N=236)